World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: German Clinical Trials Register
Last refreshed on: 8 April 2024
Main ID:  DRKS00008782
Date of registration: 08/07/2015
Prospective Registration: No
Primary sponsor: Abteilung für Medizinische Psychologie und Psychotherapie, Medizinische Soziologie und Rehabilitationswissenschaften
Public title: Evaluation of a self-management patient education program for patients with fibromyalgia syndrome.
Scientific title: Evaluation of a self-management patient education program for patients with fibromyalgia syndrome. - FimS
Date of first enrolment: 06/10/2014
Target sample size: 566
Recruitment status: Complete
URL:  http://drks.de/search/en/trial/DRKS00008782
Study type:  interventional
Study design:  Allocation: Randomized controlled study; Masking: Blinded (masking used); Control: active; Assignment: other; Study design purpose: treatment  
Phase:  N/A
Countries of recruitment
Germany
Contacts
Name: Andrea     Reusch
Address:  Klinikstraße 3 97070 Würzburg Germany
Telephone: 0931-31-82072
Email: a.reusch@uni-wuerzburg.de
Affiliation:  Abteilung für Medizinische Psychologie und Psychotherapie, Medizinische Soziologie und Rehabilitationswissenschaften
Name: Andrea    Reusch
Address:  Klinikstraße 3 97070 Würzburg Germany
Telephone: 0931-31-82072
Email: a.reusch@uni-wuerzburg.de
Affiliation:  Abteilung für Medizinische Psychologie und Psychotherapie, Medizinische Soziologie und Rehabilitationswissenschaften
Key inclusion & exclusion criteria
Inclusion criteria: patients in inpatient rehabilitation clinics with main diagnosis fibromyalgia syndrome (ICD-10: M79.7)
Exclusion criteria: insufficient German language ability, severe psychiatric comorbidity which leads to inability to participate in a group, cognitive impairment, not corrected severe visual or hearing impairment

Age minimum: 18 Years
Age maximum: None
Gender: All
Health Condition(s) or Problem(s) studied

M79.7
Fibromyalgia
M79.7
Intervention(s)
Group 1: Intervention condition is an advanced self-management patient education program for patients with fibromyalgia syndrome. This consists of 6 sessions of 90 minutes each and one optional preparing session. It should be delivered in small groups of 12 participants maximum. The program is manualized and led by physicians, psychologists and physiotherapists. Methods are interactive, with patients actively involved and different didactic methods used (interactive short lectures, group discussion, practice, individual work). Materials include presentations, flipchart, work sheets and patient information sheets. Contents of the sessions include fibromyalgia-related information (e.g. symptoms, diagnosis, course, causes and influencing factors, frequency), information about treatment (e.g. treatment options, medication, physical therapy, psychotherapy, risks and benefits of other therapies), coping with pain and stress as well as promotion of sustained physical activity. There is a focus on both self-management and transfer into everyday life through action planning.
Group 2: Control condition is the treatment as usual (education) of the respective clinic. In one cooperating clinic, this is the previously practiced, interactive patient education for fibromyalgia syndrome with 5 sessions (90 minutes each; content: illness and treatment information, coping with pain and stress, exercise therapy). In the second cooperating clinic, patients participate in a coping with pain group with 4 sessions (90 minutes each; content: information about pain, coping with pain, transfer into daily life) and receive a flyer about the fibromyalgia syndrome. In the third cooperating clinic, patients are informed by physician-delivered lectures (60 minutes each) about chronic pain, fibromyalg
Primary Outcome(s)
1) Disease- and treatment specific knowledge at discharge (also measured after 12 months): self-developed instrument
2) Self-management competence after 6 month (also measured at discharge, after 12 months): Health Education Impact Questionnaire (heiQ; Osborne et al., 2007, Schuler et al., 2013), subscales: skill and technique acquisition, self-monitoring and insight
Secondary Outcome(s)
1) Attitudes and Coping competences (discharge, after 6 months, after 12 months): 1.1) pain-related controllability: German version of the Rheumatology Attitudes Index (Leibing, Hoyer, Romatzki & Ehlers, 1999); 1.2) Acceptance of the disease and communication: self-developed instrument
2) Behavior determinants for physical activity and relaxation (discharge): Intention, action- and coping planning (self-developed instrument)
3) Behavior (after 6 months, after 12 months): 3.1) health-promoting behavior, active lifestyle: physical activity (Godin & Shephard, 1985); relaxation (self-developed according to Ströbl et al.); Health Education Impact Questionnaire (heiQ; Osborne et al., 2007, Schuler et al., 2013), subscale active engagement in life, health-promoting activities; 3.2) Interaction in the health system: Health Education Impact Questionnaire (heiQ; Osborne et al., 2007, Schuler et al., 2013), subscale health services navigation
4) Health Impairment (discharge, after 6 months, after 12 months): Fibromyalgia Impact Questionnaire without the physical functioning subscale (FIQ-G; Burckhardt et al., 1991, Offenbächer et al., 2000)
5) Depressive symptoms and anxiety (discharge, after 6 months, after 12 months): Short form of the Patient Health Questionnaire (PHQ-4; Löwe et al., 2010)
6) Participation (after 6 months, after 12 months): Fibromyalgia Participation Questionnaire (FPQ; Farin et al., 2013)
7) Socio-medical and health-economic parameters (discharge, after 6 months, after 12 months): sick leave days (not at discharge), subjective predicton of ability to work (SPE-Scale, Mittag & Raspe, 2003), treatment since rehabilitation (not at discharge)
8) Treatment satisfaction (discharge): Questionnaire of treatment satisfaction (according to Meng et al., 2009)
Secondary ID(s)
Source(s) of Monetary Support
Deutsche Rentenversicherung Bund
Secondary Sponsor(s)
Ethics review
Status: Approved
Approval date: 22/04/2014
Contact:
ethikkommission@uni-wuerzburg.de
Ethik-Kommission der Universität Würzburg, Institut für Pharmakologie und Toxikologie
+49-931-3148315
ethikkommission@uni-wuerzburg.de
Results
Results available:
Date Posted:
Date Completed: 14/01/2017
URL: http://drks.de/search/en/trial/DRKS00008782#studyResults
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history